Isarna Therapeutics Enters into a Strategic Manufacturing Agreement with Sanofi

News   Jan 10, 2014

 
Isarna Therapeutics Enters into a Strategic Manufacturing Agreement with Sanofi
 
 
 

RELATED ARTICLES

Understanding of Platelet Production Challenged By State of the Art Imaging

News

Correlative light-electron microscopy is being used to increase our knowledge of how platelets are made in the body and the results are challenging previously held understandings.

READ MORE

Research Team Discovers Compound that Stops Cancer From Spreading

News

Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.

READ MORE

Mechanism Controlling Multiple Sclerosis Risk Identified

News

Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy